France will take a stake in Sanofi's Opella through the Public Investment Bank (BPI), finance minister Antoine Armand said on ...

The proposed sale turned into a real political issue because Opella's products include Doliprane, the best-selling medicine ...

The French government needs guarantees from drugmaker Sanofi that production of its popular Doliprane painkiller will stay in ...

Politicians from across the political spectrum are up in arms over healthcare giant Sanofi's plans to sell France's ...

The French government is seeking job guarantees from drugmaker Sanofi regarding its Doliprane production sites in the event ...

India’s powerful copycat pharmaceutical industry is set to roll out generic weight loss drugs in the U.K. within weeks ...

The U.K. will study whether Lilly's weight loss drug can get people back to work and help tackle long-term sickness ...

Unions in France are planning a walkout over the planned sale of the pharmaceutical company that makes popular painkiller ...

EDITORIAL. French pharmaceutical company Sanofi's plan to sell 50% of Opella, which produces France's favorite drug, to an ...

As Sanofi moves forward with talks to potentially sell a 50% stake its consumer health unit Opella, fears of job cuts and ...

Doliprane, a brand name for paracetomol, is France's most popular medicine and has become part of the social fabric of the ...

This summary highlights global health-related news, including the WHO's approval of a vaccine for adolescents, France seeking ...